Trump Administration Finalizes Plan to Lower Drug Prices in Medicare
The Trump administration finalized a mandatory drug payment model for Medicare Part B that benchmarks prescription costs against prices in Australia and 18 other developed countries. The Global Benchmark for Efficient Drug Pricing model was officially finalized by the Centers for Medicare and Medicaid Services on October 2, 2026. However, the final version has been significantly scaled down from initial projections. Projected Medicare savings have fallen sharply compared to original estimates, leaving the program with a much narrower economic scope and a test group limited to four companies.
Listen to Live Briefing
Real-time synthesized voice briefing · Live Feeds Desk
- ✓ The Centers for Medicare and Medicaid Services finalized the Global Benchmark for Efficient Drug Pricing model on October 2, 2026.
- ✓ The mandatory drug payment model benchmarks pricing against Australia and 18 other countries.
What changed
The Centers for Medicare and Medicaid Services finalized the Global Benchmark for Efficient Drug Pricing model, which implements international price benchmarking for Medicare Part B drugs.
Live updates
-
Trump Administration Finalizes GLOBE Drug Pricing Model for Medicare
The Trump administration finalized a mandatory drug payment model for Medicare Part B that benchmarks prescription costs against prices in Australia and 18 other developed countries. The Global Benchmark for Efficient Drug Pricing model was officially finalized by the Centers for Medicare and Medicaid Services on October 2, 2026. However, the final version has been significantly scaled down from initial projections. Projected Medicare savings have fallen sharply compared to original estimates, leaving the program with a much narrower economic scope and a test group limited to four companies.
Why it matters
The administration aims to tackle high prescription costs by aligning what Medicare Part B pays with international price benchmarks. Previous proposals projected substantially higher financial returns, but revisions reduced the scope of the rule. The dramatic drop in projected savings highlights the scaling back of the administration's broader pricing agenda.
What is confirmed
- The Centers for Medicare and Medicaid Services finalized the Global Benchmark for Efficient Drug Pricing model on October 2, 2026.
- The mandatory drug payment model benchmarks pricing against Australia and 18 other countries.
Still unconfirmed
- Projected Medicare savings under the finalized GLOBE rule have fallen to $440 million or $298 million, down from an initial $11.9 billion proposal.
What to watch next
- Implementation of the four-company test under the GLOBE model
- Legal challenges regarding the economic case and legal theory of the finalized rule
confidence 95%Sources used for this update (18)
- gardnermagazine.com — Greater Gardner MA News – September 2026 – Gardner News Magazine: Local News & Articles in Gardner MA
- WSJ — Trump Administration Finalizes Plan to Lower Drug Prices in Medicare
- STAT — Trump’s watered-down Medicare drug pricing rule saves 96% less than initial proposal
- Yahoo — What Medicaid’s New Payment Model Means For Your Prescriptions
- CBC — What Trump's 'most favoured nation' drug pricing policy might mean for Canadians
- FirstWord Pharma — CMS finalises narrower GLOBE model for Medicare Part B drugs
- PharmaDispatch — US announces formal plan that benchmarks pricing against Australia and 18 other countries
- Fierce Healthcare — CMS finalizes model that aims to bring most-favored nation pricing to Part B
- Endpoints News — CMS finalizes GLOBE rule as projected Medicare savings fall from $11.9B to $440M
- www.newsbreak.com — Ford fends off Hyundai to retain No. 3 U.S. sales position in third quarter - NewsBreak
- www.devdiscourse.com — Reuters Health News Summary | International
- www.americanactionforum.org — GLOBE’s Narrowing Economic Case and Questionable Legal Theory - AAF
Community Sentiment: How do you assess this situation?
Voice your perspective · Real-time aggregated sentiment from the Live Feeds community